Literature DB >> 23881520

Two-year follow-up of a randomized controlled trial of stepped care cognitive behavioral therapy to prevent recurrence of depression in an older population.

S R A Apil1, P Spinhoven, P M J Haffmans, E Hoencamp.   

Abstract

OBJECTIVE: This study aims to determine the long-term effect of a stepped care cognitive behavioral therapy prevention program for depression in older people and the factors predicting or moderating outcome.
METHODS: In a randomized controlled trial, 136 participants, aged 55 years or older, who had been treated for depression, received during 12 months a stepped care program (SCP) or care as usual (CAU) and were then followed up for a second year. Outcome was defined as the start of a new mental health treatment for depression in a specialized outpatient setting, as recorded in the patients' electronic medical records.
RESULTS: Of the 123 patients, 38 required new mental health treatment. Survival analysis showed that participants in SCP (n = 27) required new treatment significantly more than patients receiving CAU (n = 11). Negative life events in the last year were predictive for new treatment in CAU but not in SCP.
CONCLUSIONS: An SCP seems to lower the threshold for new specialized mental health treatment for depression, whereas new treatment in CAU patients occurs more often in reaction to recent life events.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognitive behavioral therapy; depression; follow-up; older people; prevention; randomized controlled trial; stepped care

Mesh:

Year:  2013        PMID: 23881520     DOI: 10.1002/gps.4010

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  1 in total

Review 1.  The Efficacy and Cost-Effectiveness of Stepped Care Prevention and Treatment for Depressive and/or Anxiety Disorders: A Systematic Review and Meta-Analysis.

Authors:  Fiona Yan-Yee Ho; Wing-Fai Yeung; Tommy Ho-Yee Ng; Christian S Chan
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.